Medgenics (MDGN) Misses Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q1 EPS of ($0.36), $0.10 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.9 million, versus $2.14 million reported last year.
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
